Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2033161216;61217;61218 chr2:178590734;178590733;178590732chr2:179455461;179455460;179455459
N2AB1869056293;56294;56295 chr2:178590734;178590733;178590732chr2:179455461;179455460;179455459
N2A1776353512;53513;53514 chr2:178590734;178590733;178590732chr2:179455461;179455460;179455459
N2B1126634021;34022;34023 chr2:178590734;178590733;178590732chr2:179455461;179455460;179455459
Novex-11139134396;34397;34398 chr2:178590734;178590733;178590732chr2:179455461;179455460;179455459
Novex-21145834597;34598;34599 chr2:178590734;178590733;178590732chr2:179455461;179455460;179455459
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: AGA
  • RefSeq wild type template codon: TCT
  • Domain: Fn3-35
  • Domain position: 61
  • Structural Position: 92
  • Q(SASA): 0.4452
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/G rs1226541281 -1.096 None N 0.366 0.147 0.243398259712 gnomAD-2.1.1 4.04E-06 None None None None N None 0 0 None 0 5.59E-05 None 0 None 0 0 0
R/G rs1226541281 -1.096 None N 0.366 0.147 0.243398259712 gnomAD-4.0.0 1.5952E-06 None None None None N None 0 0 None 0 2.77901E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.7307 likely_pathogenic 0.7583 pathogenic -0.574 Destabilizing 0.035 N 0.519 neutral None None None None N
R/C 0.2637 likely_benign 0.2953 benign -0.534 Destabilizing 0.824 D 0.6 neutral None None None None N
R/D 0.9173 likely_pathogenic 0.9308 pathogenic 0.031 Stabilizing 0.38 N 0.593 neutral None None None None N
R/E 0.6807 likely_pathogenic 0.7205 pathogenic 0.143 Stabilizing 0.149 N 0.547 neutral None None None None N
R/F 0.7999 likely_pathogenic 0.8234 pathogenic -0.549 Destabilizing 0.555 D 0.589 neutral None None None None N
R/G 0.6987 likely_pathogenic 0.7293 pathogenic -0.856 Destabilizing None N 0.366 neutral N 0.468988928 None None N
R/H 0.1503 likely_benign 0.1838 benign -1.301 Destabilizing 0.791 D 0.554 neutral None None None None N
R/I 0.4922 ambiguous 0.5091 ambiguous 0.168 Stabilizing 0.188 N 0.603 neutral N 0.497450169 None None N
R/K 0.15 likely_benign 0.185 benign -0.519 Destabilizing 0.002 N 0.225 neutral N 0.396901959 None None N
R/L 0.4445 ambiguous 0.4773 ambiguous 0.168 Stabilizing 0.081 N 0.547 neutral None None None None N
R/M 0.5104 ambiguous 0.5399 ambiguous -0.19 Destabilizing 0.824 D 0.566 neutral None None None None N
R/N 0.8414 likely_pathogenic 0.8677 pathogenic -0.071 Destabilizing 0.149 N 0.551 neutral None None None None N
R/P 0.7943 likely_pathogenic 0.7917 pathogenic -0.058 Destabilizing 0.555 D 0.605 neutral None None None None N
R/Q 0.1714 likely_benign 0.1952 benign -0.224 Destabilizing 0.38 N 0.579 neutral None None None None N
R/S 0.7989 likely_pathogenic 0.8219 pathogenic -0.751 Destabilizing 0.062 N 0.549 neutral N 0.486675815 None None N
R/T 0.4812 ambiguous 0.4795 ambiguous -0.462 Destabilizing None N 0.365 neutral N 0.418618452 None None N
R/V 0.5608 ambiguous 0.5966 pathogenic -0.058 Destabilizing 0.081 N 0.591 neutral None None None None N
R/W 0.2899 likely_benign 0.3051 benign -0.318 Destabilizing 0.935 D 0.647 neutral None None None None N
R/Y 0.6186 likely_pathogenic 0.6619 pathogenic 0.013 Stabilizing 0.555 D 0.589 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.